Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-12-07

Clinical Trial Update: The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia [NA]

View source ↗

Summary

A clinical trial is examining how direct-acting antiviral therapy for hepatitis C affects hepatitis C–related thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct-acting antiviral therapy (Direct-acting antivirals)

Snippet

Sponsor: Assiut University | Conditions: Hepatitis C | NA | Status: UNKNOWN